BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28359264)

  • 21. Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells.
    Wise JTF; Salazar-González RA; Habil MR; Doll MA; Hein DW
    Toxicol Appl Pharmacol; 2022 May; 442():115993. PubMed ID: 35353990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
    Liu L; Wagner CR; Hanna PE
    Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
    Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
    Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
    Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
    Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA adduct levels and absence of tumors in female rapid and slow acetylator congenic hamsters administered the rat mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine.
    Fretland AJ; Devanaboyina US; Nangju NA; Leff MA; Xiao GH; Webb SJ; Doll MA; Hein DW
    J Biochem Mol Toxicol; 2001; 15(1):26-33. PubMed ID: 11170312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.
    Laurieri N; Dairou J; Egleton JE; Stanley LA; Russell AJ; Dupret JM; Sim E; Rodrigues-Lima F
    PLoS One; 2014; 9(5):e96370. PubMed ID: 24823794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
    Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
    Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Syrian hamsters congenic at the N-acetyltransferase 2 (NAT2) locus.
    Fretland AJ; Devanaboyina US; Doll MA; Zhao S; Xiao GH; Hein DW
    Toxicol Sci; 2003 Aug; 74(2):253-9. PubMed ID: 12773763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in MNU and DMBA-induced mammary tumors in female rats.
    Alvarado A; Lopes AC; Faustino-Rocha AI; Cabrita AMS; Ferreira R; Oliveira PA; Colaço B
    Pathol Res Pract; 2017 May; 213(5):441-446. PubMed ID: 28285967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.
    Kirlin WG; Trinidad A; Yerokun T; Ogolla F; Ferguson RJ; Andrews AF; Brady PK; Hein DW
    Cancer Res; 1989 May; 49(9):2448-54. PubMed ID: 2784998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus.
    Hein DW; Rustan TD; Bucher KD; Miller LS
    J Pharmacol Exp Ther; 1991 Nov; 259(2):699-704. PubMed ID: 1941618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the human N-acetyltransferase 2 genetic polymorphism in metabolism and genotoxicity of 4, 4'-methylenedianiline.
    Salazar-González RA; Zhang X; Doll MA; Lykoudi A; Hein DW
    Arch Toxicol; 2019 Aug; 93(8):2237-2246. PubMed ID: 31292670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse.
    Leff MA; Epstein PN; Doll MA; Fretland AJ; Devanaboyina US; Rustan TD; Hein DW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):182-7. PubMed ID: 10381774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
    Hein DW; Doll MA
    Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human N-acetylation of benzidine: role of NAT1 and NAT2.
    Zenser TV; Lakshmi VM; Rustan TD; Doll MA; Deitz AC; Davis BB; Hein DW
    Cancer Res; 1996 Sep; 56(17):3941-7. PubMed ID: 8752161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetyltransferase 2 (Nat2) polymorphism in the sand rat Psammomys obesus.
    Khelil M; Djerdjouri B; Tayebi B
    Toxicol Mech Methods; 2010 Oct; 20(8):440-4. PubMed ID: 20550432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
    Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
    Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
    Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
    Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.
    Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E
    BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
    Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
    Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.